Lowering LDL - Not only how low, but how long?

Michael S. Brown; Joseph L. Goldstein

doi:10.1126/science.1125884

Lowering LDL - Not only how low, but how long?

Michael S. Brown, Joseph L. Goldstein

Research output: Contribution to journal › Review article › peer-review

180 Scopus citations

Abstract

People with a mutation in a proteolytic enzyme are at a substantially lower risk for coronary heart disease because of their lifelong reduction of plasma low-density lipoprotein.

Original language	English (US)
Pages (from-to)	1721-1723
Number of pages	3
Journal	Science
Volume	311
Issue number	5768
DOIs	https://doi.org/10.1126/science.1125884
State	Published - Mar 24 2006

ASJC Scopus subject areas

General

Access to Document

10.1126/science.1125884

Cite this

@article{8038c5462b514c74a65c1bcfa0c3b291,

title = "Lowering LDL - Not only how low, but how long?",

abstract = "People with a mutation in a proteolytic enzyme are at a substantially lower risk for coronary heart disease because of their lifelong reduction of plasma low-density lipoprotein.",

author = "Brown, {Michael S.} and Goldstein, {Joseph L.}",

year = "2006",

month = mar,

day = "24",

doi = "10.1126/science.1125884",

language = "English (US)",

volume = "311",

pages = "1721--1723",

journal = "Science",

issn = "0036-8075",